“Brain Signatures Whisper Warnings:” Researchers Identify Age 9 as Critical Turning Point for Anxiety and Depression

A longitudinal study tracking children over a period of seven years identified distinct brain-wave patterns emerging from age 9 can forecast a child’s vulnerability to anxiety or depression by age 13. These predictive markers reveal divergent, hemisphere-specific neurodevelopmental trajectories. Anxiety is linked to activity on the right side of the brain, while depression is tied to the left. The findings from the novel study in Biological Psychiatry, published by Elsevier, provide a robust, externally validated foundation for early detection and targeted precision prevention.

Anxiety and depression, the two most prevalent mental disorders worldwide, are increasingly affecting younger populations, with a sharp peak during adolescence. Yet, when symptoms become severe, the window for optimal intervention has often passed. To understand how these highly comorbid disorders develop, investigators tracked the dynamic maturation of children's brains longitudinally to identify biological warning signs in children at risk before the onset of symptoms.

Researchers collected resting-state electroencephalogram (EEG) data at ages 7, 9, and 11, and assessed clinical symptoms and fMRI scans at age 13. They used advanced EEG, connectome-based predictive modeling (CPM), and machine learning to analyze the data.

The key findings are as follows:

1. Age 9 was identified as a critical neurodevelopmental turning point. At age 7, predictive brain networks were entangled, but from age 9, they diverged into distinct predictive pathways.

2. Distinct markers were found in the alpha and beta-1 EEG networks that predicted future anxiety and future depression, respectively.

3. Changes over time between ages 9 and 11 predicted symptom intensity in adolescence, with early-life anxiety/depression severity associated with more severe symptoms later in development.

4. Brain-wave signals are deeply rooted in the brain's emotional center (the amygdala): anxiety is driven by a circuit on the right side of the brain, while depression is driven by a mirror circuit on the left.

“At a time when adolescent mental health crises are rising globally, this study identifies a critical window, around age 9, and potential objective predictors for early screening, instead of subjective assessments,“ explains principal investigator Pengfei Xu, PhD, Professor, Faculty of Psychology at Beijing Normal University, and Chair of the Society for Cognitive Neuroscience, China.

By providing specific EEG networks and lateralized brain targets, these findings pave the way for early risk stratification and targeted, non-invasive preventive interventions, such as neurofeedback training or transcranial magnetic stimulation, before the onset of clinical symptoms.

First author, Guangzhi Deng, PhD candidate, Beijing Key Laboratory of Applied Experimental Psychology, Faculty of Psychology, Beijing Normal University, notes, “We were surprised to see that the brain's predictive signals for anxiety and depression were completely undifferentiated at age 7, yet they clearly separated and became highly predictive just two years later. We were also amazed by the symmetry of the underlying neural mechanisms. The right side of the brain for anxiety (avoidance/threat) and the left side of the brain for depression (reward deficit) perfectly align with classic psychological theories, bridging the gap between surface-level brain waves and deep emotional circuitry.”

When validating the models on the large, independent Healthy Brain Network (HBN) dataset, the investigators found almost identical EEG network patterns This underscores the robustness and generalizability of these indicators for early risk detection.

John Krystal, MD, Editor of Biological Psychiatry, comments, “Adolescence is a vulnerable period for the onset of anxiety and depression, yet the neurodevelopmental origins of these conditions remain unclear. This remarkable seven-year study highlights the potential utility of a biomarker for a vulnerable trajectory. Identifying when such predictive signals emerge could pinpoint a potential critical window for screening and early preventive interventions.”

"Traditionally, we wait until a teenager is in the midst of an emotional storm before seeking help,” notes Dr. Xu. “Our study demonstrates that the brain signatures whisper warnings years before the symptoms shout. We open a vital window for early intervention, potentially supporting children before symptoms even emerge. We can shift our approach from reactive treatment to proactive, personalized prevention, giving parents and clinicians a crucial head start in protecting adolescent mental health."

Notes for editors

The article is "Childhood Electroencephalographic Signatures Predict Distinct Developmental Trajectories to Adolescent Anxiety and Depression,” by Guangzhi Deng, Zheyi Zhou, Kunru Song, Hui Ai, Jintao Zhang, Yun Nan, and Pengfei Xu (https://doi-org.ucc.idm.oclc.org/10.1016/j.biopsych.2026.03.002). It is published online in Biological Psychiatry, published by Elsevier.

The article is openly available for 60 days at https://www.biologicalpsychiatryjournal.com/article/S0006-3223(26)00099-5/fulltext.

Full text of the study and additional information are also available to credentialed journalists upon request; please contact Rhiannon Bugno at [email protected]. Journalists wishing to interview the authors should contact Pengfei Xu, PhD, at [email protected].

This study was funded by the STI 2030—Major Projects (2021ZD0200500), National Natural Science Foundation of China (32371104, 32371096, 32171083, and 32371142), and the Fundamental Research Funds for the Central Universities (2243300005).

The authors’ affiliations and disclosures of financial relationships and conflicts of interest are available in the article.

John H. Krystal, MD, is Chairman of the Department of Psychiatry at the Yale University School of Medicine, Chief of Psychiatry at Yale-New Haven Hospital, and a research psychiatrist at the VA Connecticut Healthcare System. His disclosures of financial relationships and conflicts of interest are available here.

About Biological Psychiatry

Biological Psychiatry is the official journal of the Society of Biological Psychiatry, whose purpose is to promote excellence in scientific research and education in fields that investigate the nature, causes, mechanisms, and treatments of disorders of thought, emotion, or behavior. In accord with this mission, this peer-reviewed, rapid-publication, international journal publishes both basic and clinical contributions from all disciplines and research areas relevant to the pathophysiology and treatment of major psychiatric disorders.

The journal publishes novel results of original research which represent an important new lead or significant impact on the field, particularly those addressing genetic and environmental risk factors, neural circuitry and neurochemistry, and important new therapeutic approaches. Reviews and commentaries that focus on topics of current research and interest are also encouraged.

Biological Psychiatry is one of the most selective and highly cited journals in the field of psychiatric neuroscience. It is ranked 9^th out of 156 Psychiatry titles and 17^th out of 271 Neurosciences titles in Journal Citation Reports^TM, published by Clarivate. The 2024 Impact Factor score for Biological Psychiatry is 9.0.www.sobp.org/journal

About Elsevier

Elsevier is a global leader in advanced information and decision support. For over a century, we have been helping advance science and healthcare to advance human progress. We support academic and corporate research communities, doctors, nurses, future healthcare professionals and educators across 170 countries in their vital work. We do this by delivering mission-critical insights and innovative solutions that combine trusted, evidence-based scientific and medical content with cutting-edge AI technologies to help impact makers achieve better outcomes. We champion inclusion and sustainability by embedding these values into our products and culture, working with the communities that we serve. The Elsevier Foundation supports research and health partnerships around the world.

Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. For more information, visit www.elsevier.com and follow us on social media @ElsevierConnect.